Bioxytran, Inc
BIXT· OTC
Filed Apr 10, 2015 · 10-K · 100 days after period end · 0001213900-15-002590
derived · Computed from the longer spans the company filed.
| Metric | Q4 2014dderived from reported figures | Q4 2013dderived from reported figures | Q4 2012dderived from reported figures | Q4 2011dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | $148.45K | $70.64K | $23.08K |
| Net Income | -$235.27K | $111.69K | -$1.14M | -$2.55M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bioxytran, Inc · CIK 1445815 · Engraved from SEC EDGAR
ended Dec 31, 2014 · filed Apr 10, 2015 · 100 d after period end